Currently, CDEX is worth $36.4 million. Could Baxa's initial "investment" be a preliminary down payment for the purchase of CDEX? And after the first sales of the ValiMed units, it will consider purchasing the company? And if so, would CDEX pay each and every shareholder a price per share equivalent to the current market value?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.